P1376: LENALIDOMIDE–BASED MAINTENANCE AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT FOR PATIENTS WITH HIGH RISK MULTIPLE MYELOMA

• O. Pasvolsky,
• D. Milton,
• M. Rauf,
• M. Tanner,
• Q. Bashir,
• S. Srour,
• N. Saini,
• J. Ramdial,
• Y. Nieto,
• H. Lee,
• K. Patel,
• P. Kebriaei,
• S. Thomas,
• D. Weber,
• R. Orlowski,
• E. Shpall,
• R. Champlin,
• M. Qazilbash

Affiliations

O. Pasvolsky

1 Stem Cell Transplantation & Cellular Therapy

D. Milton

2 Biostatistics

M. Rauf

1 Stem Cell Transplantation & Cellular Therapy

M. Tanner

1 Stem Cell Transplantation & Cellular Therapy

Q. Bashir

1 Stem Cell Transplantation & Cellular Therapy

S. Srour

1 Stem Cell Transplantation & Cellular Therapy

N. Saini

1 Stem Cell Transplantation & Cellular Therapy

J. Ramdial

1 Stem Cell Transplantation & Cellular Therapy

Y. Nieto

1 Stem Cell Transplantation & Cellular Therapy

H. Lee

3 Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, United States of America

K. Patel

3 Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, United States of America

P. Kebriaei

1 Stem Cell Transplantation & Cellular Therapy

S. Thomas

3 Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, United States of America

D. Weber

3 Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, United States of America

R. Orlowski

3 Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, United States of America

E. Shpall

1 Stem Cell Transplantation & Cellular Therapy

R. Champlin

1 Stem Cell Transplantation & Cellular Therapy

M. Qazilbash

1 Stem Cell Transplantation & Cellular Therapy